Skip to main content
Clinical Trials/JPRN-UMIN000045086
JPRN-UMIN000045086
Completed
未知

The comparative study of the efficacy and safety of Simeprevir sodium at investigational stage and after marketing authorization - The comparative study of the efficacy and safety of Simeprevir sodium at investigational stage and after marketing authorization

Shimane University0 sites98 target enrollmentAugust 6, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic hepatitis C
Sponsor
Shimane University
Enrollment
98
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 6, 2021
End Date
December 1, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Subjects who declined use of their medical records for the study

Outcomes

Primary Outcomes

Not specified

Similar Trials